Hightower Advisors, LLC’s Eli Lilly & Co Position
Does Hightower Advisors, LLC own Eli Lilly & Co (LLY)? Yes — 440.8K shares worth $406M (+0.43% of its 13F portfolio) as of Q1 2026, down from 487.7K shares the prior filed quarter.
Position Value
$406M
Q1 2026
Shares
440.8K
% of Portfolio
+0.43%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 440.8K | $406M | +0.43% |
| Q4 2025 | 487.7K | $524M | +0.57% |
| Q3 2025 | 506.2K | $386M | +0.44% |
| Q2 2025 | 498.8K | $389M | +0.49% |
| Q1 2025 | 513.4K | $424M | +0.58% |
| Q4 2024 | 470.4K | $363M | +0.50% |
| Q3 2024 | 411.2K | $364M | +0.52% |
| Q2 2024 | 456.2K | $414M | +0.64% |
| Q1 2024 | 437.5K | $341M | +0.55% |
| Q4 2023 | 538.1K | $314M | +0.53% |
| Q3 2023 | 568.4K | $305M | +0.57% |
| Q2 2023 | 554.4K | $260M | +0.51% |
| Q1 2023 | 553.8K | $190M | +0.41% |
| Q4 2022 | 561.9K | $206M | +0.47% |
| Q3 2022 | 535.7K | $173M | +0.46% |
| Q2 2022 | 527.1K | $171M | +0.44% |
| Q1 2022 | 502.1K | $144M | +0.32% |
| Q4 2021 | 490.2K | $136M | +0.30% |
| Q3 2021 | 422.9K | $98M | +0.26% |
| Q2 2021 | 425.6K | $98M | +0.28% |
| Q1 2021 | 386.2K | $72M | +0.23% |
| Q4 2020 | 346.2K | $58M | +0.24% |
| Q3 2020 | 337.3K | $50M | +0.24% |
| Q2 2020 | 338.1K | $55M | +0.30% |
| Q1 2020 | 333.0K | $46M | +0.30% |
| Q4 2019 | 345.0K | $45M | +0.27% |
| Q3 2019 | 325.2K | $36M | +0.20% |
| Q2 2019 | 321.5K | $36M | +0.21% |
| Q1 2019 | 410.0K | $53M | +0.36% |
| Q4 2018 | 407.0K | $47M | +0.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hightower Advisors, LLC’s full portfolio or all institutional holders of LLY.